Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
85.72%Free Cash Flow to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 3.45Close
$ 1.06 - $ 6.77 52-Week Range
Ticker Information
Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQCUMBERLAND PHARMACEUTICALS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CPIX - FCF/OCF Historical data
| Date | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ 6.11M | 85.72% | $ 7.12M |
| 3/31/2025 | $ 4.07M | 75.11% | $ 5.42M |
| 12/31/2024 | $ -791.9K | 0% | $ -612.19K |
| 9/30/2024 | $ -1.72M | 0% | $ -1.48M |
| 6/30/2024 | $ -1M | 0% | $ -715.64K |
| 3/31/2024 | $ 5.04M | 93.73% | $ 5.38M |
| 12/31/2023 | $ 5.64M | 92.57% | $ 6.09M |
| 9/30/2023 | $ 6.68M | 76.91% | $ 8.69M |
| 6/30/2023 | $ 7.96M | 78.89% | $ 10.09M |
| 3/31/2023 | $ 4.98M | 69.29% | $ 7.19M |
Key Performance Insights, Last 5 Years
- CUMBERLAND PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF/OCF stands at 58.34%.
- Over the past 5 years, CUMBERLAND PHARMACEUTICALS INC's average FCF/OCF has been 81.04%.
- The median FCF/OCF for CUMBERLAND PHARMACEUTICALS INC during this period was 78.89%
- CUMBERLAND PHARMACEUTICALS INC reached its highest FCF/OCF over the past 5 years at 94.41%.
- The lowest FCF/OCF recorded by CUMBERLAND PHARMACEUTICALS INC in the same timeframe 58.34%
CUMBERLAND PHARMACEUTICALS INC's FCF/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF/OCF Benchmarks
Similar metrics to CF - Operations:
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow to Operating Cash Flow
[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].FCF / CF - Operations
(=) FCF/OCF FCF/OCF for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: FCF [ $ 3.16M ] / CF - Operations [ $ 5.42M ]
(=) FCF/OCF [ 58.34% ] CPIX - Free Cash Flow to Operating Cash Flow, Last 5 years
58.34%
Minimum
Sep 30, 2020
94.41%
Maximum
Dec 31, 2021
81.04%
Average
78.89%
Median
FCF/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.45% with a standard deviation of 29.09%.
The following table provides additional summary stats:
FCF/OCF in the Market:
| filtered constituents | 2.51K |
|---|---|
| min | -23% |
| max | 171.58% |
| average | 71.45% |
| median | 80.76% |
| std | 29.09% |